GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AR, AXL, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, GPER1, HSD17B2, IDO1, IGF1R, INSR, MMP2, MMP9, NR3C1, POLB, PPARA, SRC, TEK, TYR |
12.1969 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APP, AR, AXL, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MMP2, NR3C1, POLB, PPARA, SMAD3, SRC, TEK, TYR |
11.9449 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, APP, AR, AXL, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, POLB, PPARA, SMAD3, SRC, TEK, TYR |
10.2203 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AR, AXL, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, GPER1, HSD17B2, IDO1, NR3C1, SRC, TYR |
10.1293 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ESR1, FABP3, FABP4, FUT7, HSD11B1, HSD17B1, HSD17B2, MET, PPARA, TBXAS1 |
9.55506 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, ALOX12, APP, AR, CSNK2A1, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FLT3, GPER1, HSPA1A, IDO1, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PGR, PIM1, SMAD3, SRC, TEK, XDH |
9.25978 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, NR3C1, NR3C2, PGR, PPARA, SRC |
8.77534 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APP, AR, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, GPER1, IGF1R, INSR, MMP2, NR3C1, PPARA, SMAD3, SRC, TEK |
8.67221 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, AR, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FLT3, GPER1, NR3C1, SRC, TEK, TYR |
8.22945 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, ALOX12, APP, AR, AURKB, AXL, CA12, CA2, CA7, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, FABP3, FABP4, FLT3, GPER1, GPR35, HSD11B1, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MET, POLA1, POLB, PPARA, SMAD3, SRC, TEK, XDH |
8.2024 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, INSR, KDR, POLB, PPARA, SMAD3, SRC, TEK, TYR |
8.14968 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX12, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FUT7, HSPA1A, IDO1, PIM1, PPARA, TBXAS1, TYR, XDH |
8.14968 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, AR, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, GPER1, INSR, NR3C1, PPARA, SRC, TEK |
8.10237 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, POLA1, POLB, PPARA, SMAD3, SRC, TBXAS1, TEK, TYR, XDH |
8.10237 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
8.10237 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, NR3C1, NR3C2, PGR, PPARA, SRC |
7.91558 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP2, NR3C1, NR3C2, NUAK1, PGR, PIM1, POLA1, POLB, PPARA, SMAD3, SRC, TBXAS1, TEK, TYR, XDH |
7.75683 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, NR3C1, PGR, PIM1, PPARA, SRC |
7.75683 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, ESR1, HSD11B1, HSD17B1, HSD17B2 |
7.441 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, ALOX12, AR, AURKB, AXL, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GPER1, HSPA1A, IDO1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, XDH |
7.18048 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, ALOX12, AR, AURKB, AXL, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GPER1, HSPA1A, IDO1, IGF1R, KDR, MET, MMP9, PIM1, SMAD3, SRC, TEK, XDH |
7.07566 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.01487 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, ALOX12, AR, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IDO1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, SMAD3, SRC, TEK |
6.65637 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, ALOX12, APP, AR, AURKB, AXL, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GPER1, GPR35, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, PGR, PIM1, PPARA, SMAD3, SRC, TEK, XDH |
6.63042 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, ALOX12, APP, AXL, CA12, CA2, CA7, CNR1, EGFR, ESR1, FABP3, FABP4, FLT3, GPER1, GPR35, INSR, MET, POLA1, POLB, SMAD3, SRC |
6.47742 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, ALOX12, AR, AURKB, AXL, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GPER1, HSPA1A, IDO1, IGF1R, KDR, MMP9, PIM1, SMAD3, SRC, TEK, XDH |
6.46356 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, ALOX12, AR, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IDO1, IGF1R, KDR, MET, MMP9, PIM1, SMAD3, SRC, TEK |
6.46356 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX12, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1 |
6.46356 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX12, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD11B1, HSD17B1, HSD17B2, IDO1, TBXAS1, TYR, XDH |
6.27144 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
6.19725 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX5, ALPL, APP, AR, AXL, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRB, FABP4, GPER1, HSD17B2, IDO1, IGF1R, INSR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TYR |
6.19375 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX12, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1 |
6.17738 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ALOX12, APP, CNR1, CNR2, CYP19A1, DUSP3, EGFR, ESR1, FABP4, GPER1, HSPA1A, IDO1, IGF1R, MET, MMP2, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
6.00866 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
6.00515 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX12, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1 |
5.96428 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APP, AR, AXL, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, SMAD3, SRC |
5.90477 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, FLT3, GPER1, GPR35, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, XDH |
5.8348 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, ALOX12, AR, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IDO1, IGF1R, KDR, MMP9, PIM1, SMAD3, SRC, TEK |
5.81314 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, FLT3, GPER1, GPR35, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, XDH |
5.81314 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, POLA1, POLB, PPARA, SMAD3, SRC, TBXAS1, TEK, TYR, XDH |
5.81116 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA |
5.81116 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, FLT3, GPER1, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, SRC, TEK, XDH |
5.77493 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, APP, AR, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, INSR, KDR, MMP9, PGR, PIM1, POLB, PPARA, SMAD3, SRC, TEK, TYR |
5.77493 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, ALOX12, APP, AR, AURKB, AXL, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GPER1, GPR35, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, PGR, PIM1, PPARA, SMAD3, SRC, TEK, XDH |
5.63129 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ALOX12, APP, CYP19A1, CYP1B1, EGFR, GPER1, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.61454 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.56188 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CNR1, CNR2, CYP19A1, EGFR, ESR1, FABP4, GPER1, IDO1, PPARA, SMAD3, TEK |
5.54171 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, GPER1, NR3C1, PGR, SRC |
5.51254 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALPL, APP, AR, AURKB, AXL, CA2, CA9, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, HSD11B1, HSD17B2, INSR, KDR, MET, MMP2, MMP9, PGR, PIM1, POLB, PPARA, SMAD3, SRC, TEK, TYR |
5.39823 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD17B1, HSD17B2 |
5.33705 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.3221 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, FLT3, GPER1, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
5.31566 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ALOX12, APP, CYP19A1, CYP1B1, EGFR, GPER1, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.29273 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APP, AR, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, NUAK1, POLA1, POLB, SMAD3, SRC |
5.28328 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.28272 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, GPER1, HSD11B1, HSD17B1, HSD17B2 |
5.27049 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APP, AR, AXL, CYP1A1, CYP1B1, EGFR, ESR1, FABP4, FLT3, GPER1, IGF1R, INSR, KDR, MMP2, NR3C1, SMAD3, SRC |
5.21822 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, FLT3, GPER1, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
5.21657 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, ALPL, APP, AR, AURKB, AXL, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, NUAK1, POLA1, POLB, PPARA, SMAD3, SRC, TEK, TYR |
5.2126 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX12, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, FABP3, FABP4, FUT7, MET, PPARA, TBXAS1 |
5.18158 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, ALOX12, APP, AR, AURKB, AXL, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, FLT3, GPER1, GPR35, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
5.15368 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, POLA1, POLB, PPARA, SMAD3, SRC, TBXAS1, TEK, TYR, XDH |
5.14708 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AR, AXL, CYP1B1, EGFR, FLT3, GPER1, GPR35, HSPA1A, INSR, KDR, MET, SRC, TEK, XDH |
5.11755 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AR, AXL, CNR1, CSNK2A1, CYP1B1, EGFR, ESRRA, FABP4, FLT3, GPER1, GPR35, HSPA1A, IDO1, INSR, KDR, MET, MMP2, MMP9, SMAD3, SRC, TEK, XDH |
5.07111 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, AR, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, GPER1, NR3C1, SRC |
5.07051 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ALOX12, APP, EGFR, GPER1, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.03605 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA |
5.035 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, CNR1, CNR2, EGFR, FABP3, FLT3, GPER1, IGF1R, INSR, MMP2, PPARA, SRC, TEK, TYR |
4.97174 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, APP, AR, AURKB, AXL, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPER1, GPR35, HSPA1A, IDO1, IGF1R, KDR, MET, MMP9, NR3C1, PIM1, PPARA, SMAD3, SRC, TEK, XDH |
4.92029 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ALOX12, APP, CYP19A1, CYP1B1, EGFR, GPER1, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.90025 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ALOX12, APP, EGFR, GPER1, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.89436 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX12, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1 |
4.89436 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ALOX12, APP, CYP19A1, CYP1B1, EGFR, GPER1, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.89288 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MMP9, SRC |
4.86508 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX12, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1 |
4.84494 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, ALOX12, CNR1, CNR2, CYP19A1, EGFR, ESR1, FABP4, GPER1, IDO1, KDR, MET, PPARA, SMAD3, TEK |
4.84494 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CNR1, CNR2, CYP19A1, EGFR, ESR1, FABP4, GPER1, HSPA1A, IDO1, MMP2, PPARA, SMAD3, SRC, TEK |
4.82014 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ALOX12, APP, EGFR, GPER1, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.79667 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX12, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA, TBXAS1 |
4.79667 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, CNR1, CNR2 |
4.7713 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.7032 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ALOX12, AR, CNR1, CNR2, CYP19A1, DUSP3, EGFR, ESR1, ESR2, GPER1, HSPA1A, IGF1R, MET, MMP9, PPARA, SMAD3, SRC, TEK, XDH |
4.67493 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ALOX12, APP, EGFR, GPER1, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.6466 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, ALOX12, APP, CA12, CA2, CA7, CNR1, EGFR, ESR1, FABP3, FABP4, GPER1, GPR35, INSR, MET, SMAD3 |
4.61285 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, CNR1, CNR2, EGFR, FABP3, FLT3, GPER1, IGF1R, INSR, MMP2, PPARA, SRC, TEK, TYR |
4.61285 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, APP, AR, AXL, CSNK2A1, CYP1B1, EGFR, FLT3, GPER1, GPR35, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, XDH |
4.55796 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CNR2, CYP19A1, GPER1, PPARA, SMAD3, TEK |
4.53781 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, APP, AR, AURKB, AXL, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPER1, GPR35, HSPA1A, IDO1, IGF1R, KDR, MET, MMP9, NR3C1, PGR, PIM1, PPARA, SMAD3, SRC, TEK, XDH |
4.40747 |
[BP] GO:0071383 |
None
|
AR, EGFR, FLT3, GPER1, NR3C1, SRC |
4.37702 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CYP1B1, EGFR, ESR1, GPER1, IGF1R, INSR, MMP2, MMP9, NR3C1, SRC |
4.27611 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, ALOX12, AR, CSNK2A1, EGFR, ESR1, FLT3, GPER1, IGF1R, INSR, KDR, MMP2, MMP9, PIM1, TEK |
4.22012 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ALOX12, APP, AR, AXL, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1B1, EGFR, GPER1, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PPARA, SMAD3, SRC, TEK |
4.18271 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, CYP1A1, EGFR, ESR1, FLT3, MET, PIM1, POLA1, SRC, TEK, TYR |
4.17213 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, DUSP3, ESR1, FABP4, GPR35, IGF1R, MET, MMP9, PIM1, PPARA, SRC |
4.15023 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AR, AURKB, AXL, CNR1, ESR1, GPER1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK |
4.12757 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.98272 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, AR, EGFR, ESR1, FLT3, GPER1, IGF1R, INSR, MMP2, NR3C1, SMAD3, SRC |
3.98272 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AR, AXL, CNR1, CYP19A1, CYP1A1, EGFR, ESR1, ESRRB, HSD17B2, IDO1, INSR, MMP2, MMP9, PGR, SRC |
3.94929 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, HSPA1A, IDO1, MMP1, MMP2, MMP9, SRC, XDH |
3.93819 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, EGFR, GPER1, INSR, MET, SRC, TEK, XDH |
3.9249 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, APP, AR, AXL, CA1, CA2, CNR1, CNR2, CSNK2A1, CYP1B1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GPR35, IGF1R, INSR, KDR, MET, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, POLB, PPARA, SMAD3, SRC, TEK |
3.90161 |
[BP] GO:0032787 |
None
|
ALOX12, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, IDO1, PPARA, TBXAS1 |
3.8843 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ALOX12, APP, AR, AXL, CA2, CNR1, CYP1B1, EGFR, ESRRB, GPER1, HSPA1A, IDO1, KDR, MET, MMP9, PIM1, SMAD3, SRC, TEK |
3.85443 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, APP, AR, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, FABP4, FLT3, GPER1, GPR35, HSPA1A, IGF1R, INSR, MET, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, XDH |
3.81877 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, AR, CA2, EGFR, FLT3, GPER1, NR3C1, SRC |
3.81865 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, CNR1, CNR2, EGFR, GPER1 |
3.79627 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, CNR1, CNR2, EGFR, GPER1 |
3.79627 |
[BP] GO:0010676 |
None
|
ESRRB, GPER1, INSR, PPARA, SRC |
3.79627 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, APP, AR, DUSP3, EGFR, FLT3, GPER1, IGF1R, INSR, KDR, SRC, TEK, XDH |
3.77698 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, SRC, TEK |
3.735 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, APP, AR, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, GPER1, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
3.70535 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1B1, KDR, POLB, SRC |
3.70491 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.70491 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.69305 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.68944 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.68944 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, CA9, CNR1, CNR2, CYP1A1, CYP1B1, EGFR, FABP3, KDR, NR3C1, POLB, SRC |
3.68339 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, APP, AR, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, GPER1, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
3.67383 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, APP, AR, EGFR, FLT3, GPER1, INSR, KDR, SRC, TEK, XDH |
3.66334 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, AR, CNR2, DUSP3, EGFR, ESR1, ESR2, GPER1, GPR35, HSPA1A, IGF1R, MET, MMP9, SMAD3, SRC, XDH |
3.66334 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, AR, CNR2, DUSP3, EGFR, ESR1, ESR2, GPER1, GPR35, HSPA1A, IGF1R, MET, MMP9, SMAD3, SRC, XDH |
3.64759 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, EGFR, HSPA1A, MMP2, POLB, PPARA, SMAD3, SRC, TEK, TYR |
3.64248 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, AR, AURKB, CNR1, CNR2, CSNK2A1, DUSP3, EGFR, ESR1, FABP4, FLT3, GPER1, HSPA1A, IGF1R, INSR, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
3.59516 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ALOX12, APP, AR, AXL, CA2, CNR1, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, GPER1, GPR35, HSPA1A, IDO1, INSR, KDR, MET, MMP9, PIM1, SMAD3, SRC, TEK, XDH |
3.59516 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, EGFR, HSPA1A, IDO1 |
3.54459 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.54091 |
[BP] GO:0050866 |
negative regulation of cell activation
|
ALOX12, AXL, CNR1, CNR2, DUSP3, GPER1, IDO1 |
3.53635 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CNR2, CYP19A1, GPER1, PPARA, SMAD3, TEK |
3.52199 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD17B1, HSD17B2 |
3.51376 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, EGFR, NR3C1, SRC |
3.41397 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, GPER1, IGF1R, INSR, PPARA, SRC, TEK |
3.34748 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, SMAD3, SRC, TEK |
3.34088 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.30796 |
[BP] GO:0045913 |
None
|
ESRRB, GPER1, INSR, PPARA, SRC |
3.29606 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, EGFR, GPER1 |
3.28144 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CNR1, CYP1A1, FABP3, FLT3, GPER1, PPARA, SRC, TEK |
3.22295 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.22295 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, APP, AR, EGFR, ESRRB, FABP3, FLT3, GPER1, INSR, KDR, MMP9, SMAD3, SRC, TEK, XDH |
3.19666 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, APP, AR, EGFR, ESRRB, FABP3, FLT3, GPER1, INSR, KDR, MMP9, SMAD3, SRC, TEK, XDH |
3.19666 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.19666 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
3.19666 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, IDO1, SRC |
3.17285 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, ALOX12, CNR2, CYP19A1, GPER1, PPARA, SMAD3, TEK |
3.15378 |
[BP] GO:0051094 |
positive regulation of developmental process
|
ALOX12, APP, AR, AXL, CA2, CNR1, CYP1B1, ESRRB, GPER1, IDO1, INSR, KDR, PIM1, SMAD3, SRC, TEK |
3.15378 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
AR, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
3.12527 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
3.10935 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AR, AXL, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, PGR, SRC |
3.08058 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, FLT3, GPER1, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
3.05118 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX12, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, IDO1, PIM1, PPARA, TBXAS1, TYR |
3.04258 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, MMP2, POLB, PPARA, SMAD3, SRC, TEK |
3.04147 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, CSNK2A1, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLB, SRC, TEK, XDH |
3.02403 |
[BP] GO:0045759 |
None
|
CNR1, CNR2, GPR35 |
3.00352 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, IDO1, SRC |
2.99422 |
[BP] GO:1901655 |
None
|
AKR1B1, AR, EGFR, NR3C1, SRC |
2.97417 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APP, AR, AURKB, CNR1, CNR2, CSNK2A1, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, GPER1, HSPA1A, IGF1R, KDR, MET, MMP9, NR3C1, PGR, PPARA, SMAD3, SRC, XDH |
2.96198 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AR, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, GPER1, IGF1R, INSR, KDR, MET, NR3C1, PGR, PPARA, SMAD3, SRC |
2.96198 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, APP, AR, AURKB, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NR3C1, PGR, PPARA, SMAD3, SRC, TEK, XDH |
2.94955 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.90583 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.89606 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AR, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, GPER1, IGF1R, INSR, KDR, MET, NR3C1, PGR, PPARA, SMAD3, SRC |
2.89606 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AXL, CA2, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, EGFR, GPER1, HSPA1A, IDO1, MMP2, MMP9, NUAK1, POLA1, POLB, PPARA, SMAD3, SRC, TEK |
2.89606 |
[BP] GO:0042058 |
None
|
ADORA1, APP, EGFR, GPER1, MMP9 |
2.87219 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, APP, AR, DUSP3, EGFR, ESRRB, FABP4, FLT3, GPER1, IGF1R, INSR, KDR, MMP9, PPARA, SRC, TEK, XDH |
2.86778 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.82094 |
[BP] GO:0002695 |
negative regulation of leukocyte activation
|
AXL, CNR1, CNR2, DUSP3, GPER1, IDO1 |
2.81224 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
2.81224 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.80254 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, INSR, MET, SRC, TEK |
2.80132 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, CSNK2A1, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLB, SRC, TEK, XDH |
2.77411 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, EGFR, FLT3, GPER1, NR3C1, SRC |
2.75909 |
[BP] GO:0050793 |
regulation of developmental process
|
ALOX12, APP, AR, AXL, CA2, CNR1, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, GPER1, IDO1, INSR, KDR, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, XDH |
2.72167 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AR, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSPA1A, IGF1R, INSR, MET, NR3C1, PGR, PPARA, SMAD3, SRC |
2.71339 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
ALOX12, APP, AR, AXL, CA2, CNR1, CYP1B1, EGFR, ESR1, ESRRA, GPER1, IDO1, INSR, KDR, PIM1, SMAD3, SRC, TEK, XDH |
2.69738 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AR, AXL, CNR1, CYP1A1, EGFR, ESR1, PGR, SRC |
2.68626 |
[BP] GO:0048732 |
gland development
|
AR, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
2.6656 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
2.6656 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.6656 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX12, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, IDO1, PIM1, PPARA, TBXAS1, TYR |
2.65613 |
[BP] GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling
|
EGFR, FLT3, GPER1, KDR, TEK |
2.65531 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
APP, EGFR, INSR, KDR, NR3C1, SMAD3, SRC |
2.63958 |
[BP] GO:1901184 |
None
|
ADORA1, APP, EGFR, GPER1, MMP9 |
2.61618 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
2.60564 |
[BP] GO:0032870 |
cellular response to hormone stimulus
|
AR, EGFR, ESR1, FLT3, GPER1, INSR, NR3C1, SRC |
2.60564 |
[BP] GO:0000904 |
cell morphogenesis involved in differentiation
|
AR, AXL, MET, SRC, TEK |
2.60066 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX12, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, IDO1, PIM1, PPARA, TBXAS1, TYR |
2.59074 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, APP, AR, AURKB, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NR3C1, PGR, PPARA, SMAD3, SRC, TEK, XDH |
2.59074 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.59074 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.59074 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.59074 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.59074 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, APP, AR, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NR3C1, PGR, PPARA, SMAD3, SRC, TEK, XDH |
2.58949 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
ALOX12, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.57368 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AR, AURKB, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NR3C1, PGR, PPARA, SMAD3, SRC, TEK, XDH |
2.57215 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX12, APP, AR, AURKB, AXL, CNR1, CSNK2A1, EGFR, ESR1, ESR2, GPER1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK |
2.56275 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AR, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, GPER1, IGF1R, INSR, MET, NR3C1, PGR, PPARA, SMAD3, SRC |
2.56275 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, AR, CYP1B1, FABP3, GPER1, HSPA1A, IDO1, SMAD3, XDH |
2.54711 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
2.52781 |
[BP] GO:0048729 |
tissue morphogenesis
|
AR, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.52639 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, MMP2, PPARA, SMAD3, SRC, TEK |
2.52293 |
[BP] GO:0071396 |
cellular response to lipid
|
AR, AXL, EGFR, ESR1, FLT3, GPER1, NR3C1, SRC |
2.52293 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, APP, AR, EGFR, ESRRB, FLT3, GPER1, INSR, KDR, MMP9, SRC, TEK, XDH |
2.50907 |
[BP] GO:0060748 |
None
|
AR, PGR |
2.50907 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.50907 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.50907 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.49961 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.48703 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.48703 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, CYP1A1, EGFR, PPARA, SMAD3 |
2.48107 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.46654 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, CNR1, EGFR, GPER1, KDR, SRC |
2.4642 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, SMAD3, SRC, TEK |
2.45947 |
[BP] GO:0051254 |
None
|
APP, AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSPA1A, INSR, MET, NR3C1, PGR, PPARA, SMAD3, SRC |
2.44129 |
[BP] GO:0009653 |
anatomical structure morphogenesis
|
APP, AR, AXL, CA2, CA9, CYP1B1, EGFR, ESR1, INSR, MET, MMP2, POLB, SMAD3, SRC, TEK |
2.43687 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, CYP19A1, ESR1, HSD17B2, INSR, SRC |
2.43687 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.43687 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APP, AURKB, CYP1A1, DUSP3, EGFR, GPER1, INSR, SRC |
2.42617 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.41189 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
APP, DUSP3, EGFR, GPER1, KDR, SRC, TEK |
2.40288 |
[BP] GO:0001503 |
ossification
|
ALPL, EGFR, MMP2, MMP9, TEK |
2.39382 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
AURKB, GPER1, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
2.36119 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
CNR1, EGFR, FABP4, IDO1, KDR, MET, SMAD3 |
2.36119 |
[BP] GO:0070848 |
response to growth factor
|
APP, EGFR, INSR, KDR, NR3C1, SMAD3, SRC |
2.36119 |
[BP] GO:0071384 |
None
|
EGFR, FLT3, GPER1, NR3C1 |
2.33649 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, EGFR, KDR, NR3C1, SRC |
2.33504 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX12, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GPER1, GPR35, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, POLA1, POLB, PPARA, SMAD3, SRC, TBXAS1, TEK, TYR, XDH |
2.32669 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.32669 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, APP, AR, AURKB, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, POLA1, PPARA, SMAD3, SRC, TEK, XDH |
2.32347 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, EGFR, ESR1, PGR, PPARA, SRC |
2.32347 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, APP, AXL, CA2, CNR1, CNR2, CYP19A1, DUSP3, ESR1, ESRRA, GPER1, HSPA1A, IDO1, MMP2, SMAD3, SRC |
2.31756 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
ADORA3, APP, AR, CYP1B1, ESR1, ESR2, HSPA1A, PIM1 |
2.31756 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
APP, EGFR, GPER1, KDR, SRC, TEK |
2.29505 |
[BP] GO:0010675 |
None
|
ESRRB, GPER1, INSR, PPARA, SRC |
2.29505 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.2792 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, EGFR, GPER1, IGF1R, INSR, MMP2, SRC |
2.27737 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.27737 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.27737 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.27737 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.27737 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, SRC, TEK |
2.27737 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, APP, AR, DUSP3, EGFR, FABP4, FLT3, GPER1, IGF1R, INSR, KDR, MMP9, SRC, TEK, XDH |
2.27324 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, EGFR, ESR1, ESRRA, GPER1 |
2.26498 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, HSPA1A, IDO1, XDH |
2.25602 |
[BP] GO:0042391 |
None
|
ADORA1, APP, CNR1, CNR2, GPER1, GPR35, KDR, SRC |
2.255 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.255 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, SRC, TEK |
2.255 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
DUSP3, ESR1, GPER1, HSPA1A, IGF1R, MET, MMP9, SRC, XDH |
2.25395 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.25395 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.25395 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD17B1, HSD17B2 |
2.24608 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, MET, MMP9, PPARA, SRC |
2.23566 |
[BP] GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling
|
FLT3, GPER1, KDR, TEK |
2.22779 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, GPER1, MMP9, SMAD3, SRC, XDH |
2.22676 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, APP, AR, AURKB, EGFR, ESR1, ESR2, FLT3, GPER1, HSPA1A, INSR, MET, MMP9, SMAD3, SRC, TEK, XDH |
2.22582 |
[BP] GO:0002683 |
negative regulation of immune system process
|
ADORA1, AXL, CNR1, CNR2, CYP19A1, DUSP3, GPER1, IDO1 |
2.22469 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, GPER1, MMP2, MMP9 |
2.2219 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APP, GPER1, IGF1R, INSR, SRC |
2.21183 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, GPER1, KDR, SRC |
2.21183 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AR, AURKB, AXL, CSNK2A1, CYP1A1, CYP1A2, DUSP3, EGFR, ESR1, FLT3, FUT7, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, POLB, PPARA, SMAD3, SRC, TEK, TYR, XDH |
2.21183 |
[BP] GO:0040008 |
regulation of growth
|
ALOX12, APP, AR, CSNK2A1, EGFR, ESR2, HSPA1A, INSR, PIM1, SMAD3 |
2.21183 |
[BP] GO:0045893 |
None
|
APP, AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, GPER1, INSR, MET, NR3C1, PGR, PPARA, SMAD3, SRC |
2.19568 |
[BP] GO:1903508 |
None
|
APP, AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, GPER1, INSR, MET, NR3C1, PGR, PPARA, SMAD3, SRC |
2.19568 |
[BP] GO:1902680 |
None
|
APP, AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, GPER1, INSR, MET, NR3C1, PGR, PPARA, SMAD3, SRC |
2.19391 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX12, APP, CYP19A1, CYP1A1, CYP1B1, TYR |
2.1833 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, IDO1 |
2.17688 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.17688 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, APP, AR, DUSP3, EGFR, FABP4, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, SRC, TEK, XDH |
2.17046 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, APP, AR, EGFR, FLT3, GPER1, INSR, KDR, MMP9, SRC, TEK, XDH |
2.16664 |
[BP] GO:1901360 |
None
|
ACHE, AKR1B1, AKR1B10, ALOX12, AOX1, APP, AR, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IDO1, NR3C1, NR3C2, PGR, POLA1, POLB, PPARA, SMAD3, TYR, XDH |
2.15787 |
[BP] GO:0050801 |
ion homeostasis
|
APP, CA12, CA2, CA7, EGFR, ESR1, FABP3, GPER1, GPR35, SMAD3 |
2.14677 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX12, CYP1B1, DUSP3, IDO1, KDR, NUAK1, PPARA, SMAD3, SRC, TEK |
2.14677 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
2.12356 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.11824 |
[BP] GO:2000241 |
regulation of reproductive process
|
AR, CNR1, ESR1, INSR, SRC |
2.10528 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, EGFR, GPER1, IGF1R, INSR, MMP2, SRC |
2.10528 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, APP, AR, CSNK2A1, EGFR, ESR1, FLT3, GPER1, HSPA1A, INSR, KDR, MMP9, SMAD3, SRC, TEK, XDH |
2.10528 |
[BP] GO:0010038 |
response to metal ion
|
APP, CA2, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.09896 |
[BP] GO:0046320 |
None
|
CNR1, FABP3, PPARA |
2.09896 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX12, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD17B1, HSD17B2 |
2.08704 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, SRC |
2.07761 |
[BP] GO:0050865 |
regulation of cell activation
|
ALOX12, APP, AXL, CNR1, CNR2, DUSP3, GPER1, IDO1, SRC |
2.06717 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, CNR1, EGFR, GPER1 |
2.06036 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.04783 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9 |
2.04783 |
[BP] GO:0050678 |
None
|
AR, EGFR, KDR, PGR, SMAD3, TEK, XDH |
2.02614 |
[BP] GO:0035265 |
organ growth
|
AR, CYP19A1, ESR1 |
2.02614 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, SRC, TEK |
2.02614 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.02614 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX5, AOX1, APP, AR, AURKB, CA1, CA2, CA4, CA7, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GPER1, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IDO1, INSR, KDR, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, POLA1, SMAD3, SRC, TBXAS1, TYR, XDH |
2.4396 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, TEK |
2.406 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX12, ALOX5, ALPL, APP, AR, AXL, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ESR1, FLT3, FUT7, GPER1, GPR35, HSD11B1, HSD17B2, IGF1R, INSR, KDR, MET, MMP2, NR3C2, PGR, PIM1, SMAD3, SRC, TBXAS1, TEK, TYR |
2.36119 |
[CC] GO:0045121 |
membrane raft
|
APP, CNR1, EGFR, INSR, KDR, SRC, TEK |
2.26498 |
[CC] GO:0098857 |
membrane microdomain
|
APP, CNR1, EGFR, INSR, KDR, SRC, TEK |
2.255 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, GPER1, HSD11B1, HSD17B2, NR3C2, TBXAS1 |
2.25395 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ALOX12, ALPL, APP, AR, AXL, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CSNK2A1, EGFR, ESR1, FLT3, GPER1, GPR35, IGF1R, INSR, KDR, MET, MMP2, PIM1, SMAD3, SRC, TEK |
2.14677 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, FLT3, GPER1, HSD11B1, HSD17B2, NR3C2, TBXAS1 |
2.07243 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, CA4, CNR1, CNR2, FLT3, GPER1, GPR35, IGF1R, INSR, KDR, MET, TEK |
2.04937 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX12, ALOX5, AOX1, APP, AR, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, SMAD3, TBXAS1, TYR, XDH |
18.6928 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX12, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, POLA1, POLB, PPARA, SMAD3, SRC, TBXAS1, TEK, TYR, XDH |
12.1865 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, NR3C1, NR3C2, PGR, PPARA |
10.4972 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSD17B1, NR3C1, NR3C2, PGR, SHBG |
10.4972 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.1293 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, SRC, TBXAS1, TEK, TYR, XDH |
8.40463 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PGR, PPARA |
8.14968 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PGR, PPARA |
8.14968 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX12, ALOX5, ALPL, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, IDO1, MMP1, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, POLA1, POLB, PPARA, SMAD3, TBXAS1, TYR, XDH |
8.10685 |
[MF] GO:0005506 |
iron ion binding
|
ALOX12, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1, XDH |
8.10137 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, EGFR, GPER1, HSD17B1, IGF1R, INSR, NR3C1, SHBG |
7.88977 |
[MF] GO:0046872 |
metal ion binding
|
ALOX12, ALOX5, ALPL, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, IDO1, MMP1, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, POLA1, POLB, PPARA, SMAD3, TBXAS1, TYR, XDH |
7.82024 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, NR3C1, NR3C2, PGR, PPARA, SMAD3 |
7.70435 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX12, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD11B1, HSD17B1, HSD17B2, IDO1, TBXAS1, TYR, XDH |
7.52881 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.52881 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AR, AXL, CNR1, CNR2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GPR35, IGF1R, INSR, KDR, MET, NR3C1, NR3C2, PGR, PPARA, TEK |
7.12737 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, POLB |
6.91891 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.7552 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.7552 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, IDO1, SRC, TBXAS1 |
6.48781 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.4146 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, IDO1, SRC, TBXAS1 |
6.26065 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AR, AXL, CNR1, CNR2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GPR35, IGF1R, INSR, KDR, MET, NR3C1, NR3C2, PGR, PPARA, TEK |
6.24853 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1, TYR |
6.21855 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AR, AXL, CNR1, CNR2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GPR35, IGF1R, INSR, KDR, MET, NR3C1, NR3C2, PGR, PPARA, SMAD3, TEK |
6.19725 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AR, AXL, CNR1, CNR2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GPR35, IGF1R, INSR, KDR, MET, NR3C1, NR3C2, PGR, PPARA, TEK |
6.02985 |
[MF] GO:0008289 |
lipid binding
|
AR, AXL, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPER1, HSD17B1, NR3C1, NR3C2, PGR, PPARA, SHBG |
5.53015 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, IDO1, POLA1, SRC, TBXAS1, XDH |
5.48607 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.40301 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
5.38611 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, SRC, TEK |
4.9267 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1, TYR |
4.84494 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, POLB |
4.32644 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
4.17623 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2, GPER1 |
4.151 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD17B1, HSD17B2, XDH |
4.08221 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
4.07503 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, AOX1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, HSD17B1, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, NR3C1, NR3C2, NUAK1, PGR, PIM1, POLA1, POLB, PPARA, SHBG, SMAD3, SRC, TBXAS1, TEK, XDH |
3.70491 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLA1, POLB, SRC, TEK |
3.60252 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
3.54091 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.41497 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.35943 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6 |
3.15378 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP9, PIM1, PPARA, SMAD3, SRC |
3.08058 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.05118 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ADORA1, AOX1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD17B1, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, NR3C1, NR3C2, NUAK1, PGR, PIM1, POLA1, POLB, PPARA, SMAD3, SRC, TBXAS1, TEK, XDH |
2.96504 |
[MF] GO:0019899 |
enzyme binding
|
APP, AR, AURKB, CYP1A1, CYP1A2, CYP2A6, DUSP3, EGFR, ESR1, ESR2, ESRRB, HSPA1A, MET, NR3C1, PGR, POLA1, POLB, PPARA, SMAD3, SRC, TEK |
2.90481 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.89606 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.89606 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.76829 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP9, PPARA, SMAD3, SRC |
2.72824 |
[MF] GO:0031072 |
heat shock protein binding
|
ADORA1, CSNK2A1, HSPA1A, KDR, NR3C1 |
2.52534 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.50907 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AOX1, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLA1, SRC, TEK, XDH |
2.333 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD17B1, HSD17B2 |
2.32347 |
[MF] GO:0000978 |
None
|
AR, ESR1, ESR2, ESRRA, NR3C1, PGR, PPARA, SMAD3 |
2.27737 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.27737 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.27737 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.27737 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.19679 |
[MF] GO:0000987 |
None
|
AR, ESR1, ESR2, ESRRA, NR3C1, PGR, PPARA, SMAD3 |
2.19391 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, CNR1, CNR2, EGFR, FLT3, GPER1, GPR35, IGF1R, INSR, KDR, MET, TEK |
2.1833 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, CNR1, CNR2, EGFR, FLT3, GPER1, GPR35, IGF1R, INSR, KDR, MET, TEK |
2.1833 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX12, ALOX5, IDO1 |
2.17688 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD17B1, HSD17B2 |
2.13707 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX12, ALOX5, IDO1 |
2.13707 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.11732 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, APP, CSNK2A1, EGFR, ESR1, ESR2, FLT3, IGF1R, KDR, MET, MMP9, PGR, SMAD3, TYR, XDH |
2.08715 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD17B1, HSD17B2 |
2.06121 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.06121 |